Previous 10 | Next 10 |
home / stock / wxxwy / wxxwy news
Drugs services provider WuXi Biologics has issued a positive earnings alert for the first half of the year, predicting revenue would rise by up to 63% and net profit would jump as much as 37%. The provider of outsourced pharmaceutical services has delivered on bullish market hopes of ...
WuXi Biologics Plans to Build a Comprehensive CRDMO Center in Singapore PR Newswire This investment will establish a cutting-edge, fully integrated CRDMO center in Singapore , including a research and development service center and large-scale drug substance and dr...
Pfizer ( NYSE: PFE ) backed Chinese cancer drugmaker CStone Pharmaceuticals ( OTCPK:CSPHF ) is exploring strategic options, including a sale of the company, Bloomberg News reported citing people with knowledge of the matter. WuXi Healthcare Ventures, a unit of...
WuXi Vaccines said it received a GMP (Good Manufacturing Practice) certificate from Ireland Health Products Regulatory Authority for its QC potency lab in Dundalk, Ireland. WuXi Vaccines, which is a joint venture between WuXi Biologics ( OTCPK:WXXWY ) and Shanghai Hil...
Contract manufacturing organization WuXi XDC, a joint venture between WuXi Biologics ( OTCPK:WXXWY ) and WuXi STA, is collaborating with South Korean antibody-drug conjugates (ADC) maker AbTis. Under the agreement, AbTis will use WuXi XDC's integrated services fo...
WuXi Biologics ( OTCPK:WXXWY ) ( OTCPK:WXIBF ) gained nearly 12% on Tuesday after Reuters reported that the Wuxi, China-based life sciences company is one step closer to getting off the U.S. Commerce Department's "Unverified List." According to a department official, C...
WuXi Biologics Launches First Commercial Drug Product Facility for Pre-Filled Syringes PR Newswire WuXi Biologics offers global partners high-efficiency and high-quality manufacturing services for clinical trial and commercial supply by increasing pre-filled syringes (...
We had previously owned WuXi Biologic shares but sold it in the second quarter of 2019. We bought back WXIBF stock after a sharp price correction in the first quarter of 2021. The rapid development of several antibody drugs for COVID-19 gave a further, unexpected boost to WuXi...
Harding Loevner has been investing globally in high-quality, growing businesses based on disciplined industry research since 1989. Stock markets fell in the quarter, as the world watched in horror Russia’s invasion of Ukraine. China-based WuXi Biologics illustrates the perf...
Vir Biotechnology (NASDAQ:VIR) announced on Friday that its Chinese partner WuXi Biologics (OTCPK:WXXWY) (OTCPK:WXIBF) ended its partnership for development and manufacturing for several of company’s antibody drugs including the COVID-19 antibody therapy sotrovimab. Per the terms of th...
News, Short Squeeze, Breakout and More Instantly...
Wuxi Biologics Cayman Inc ADR Company Name:
WXXWY Stock Symbol:
OTCMKTS Market:
WuXi Biologics Named Constituent of the FTSE4Good Index Series for Fourth Year PR Newswire SHANGHAI , July 10, 2024 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), anno...
WuXi Biologics Successfully Implemented a Fully Integrated Continuous Process with a Breakthrough Productivity of ~6 g/L/day at Pilot Scale PR Newswire By leveraging WuXiUP TM , WuXi Biologics has completed its first end-to-end continuous drug substance (DS) manufacturing ...
WuXi Biologics Receives AAA MSCI ESG Rating PR Newswire SHANGHAI , Nov. 7, 2023 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced it has received an AAA rating ...